Pretax income is the income that a company earns before paying income taxes. MetaStat's pretax income for the
three
months ended in Feb. 2018 was $-0.97 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Feb. 2018 was $-3.18 Mil.
MetaStat's pretax margin was %.
MetaStat Pre-Tax Income Historical Data
The historical data trend for MetaStat's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of MetaStat's Pre-Tax Income
For the Biotechnology subindustry, MetaStat's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MetaStat's Pre-Tax Income Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, MetaStat's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where MetaStat's Pre-Tax Income falls into.
MetaStat Pre-Tax Income Calculation
This is the income that a company earns before paying income taxes.
MetaStat's Pretax Income for the fiscal year that ended in Feb. 2018 is calculated as
Pre-Tax Income for the trailing twelve months (TTM) ended in Feb. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.18 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MetaStat (OTCPK:MTST) Pre-Tax Income Explanation
MetaStat's Pretax Margin for the quarter that ended in Feb. 2018 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MetaStat Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of MetaStat's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
MetaStat Inc is a US-based biotechnology company which focuses on discovering and developing personalized therapeutic (Rx) and diagnostic (Dx) treatment solutions for cancer patients. The company focuses on development programs of the novel therapeutic product candidates that target the Mena protein isoform whereas the Companion Diagnostics program is focused on developing companion tests to be used in combination with cancer drugs, that provide essential information for the safe and effective use of a corresponding drug or biological product to improve patient outcome. It also develops a prognostic diagnostic program which is focused on developing diagnostic tests that predict the risk of future metastasis in cancer patients following the initial treatment of their primary tumor.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
MTST has been successfully added to your 